Get started
Author

Julie Gay

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
2019 · Paul G Richardson, Albert Oriol, et al. · The Lancet Oncology · 405
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura
2014 · Miguel Hie, Julie Gay, et al. · Blood · 200
PDF
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
2024 · Xavier Leleu, Cyrille Hulin, et al. · Nature Medicine · 144
PDF
Early Human Herpesvirus Type 6 Reactivation after Allogeneic Stem Cell Transplantation: A Large-Scale Clinical Study
2011 · Rémy Dulery, Julia Salleron, et al. · Transplantation and Cellular Therapy · 117
PDF
Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma
2025 · Aurore Perrot, Jérôme Lambert, et al. · New England Journal of Medicine · 91
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 + Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia
2024 · Patrice Chevallier, Thibaut Leguay, et al. · Journal of Clinical Oncology · 53
Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial
2025 · Aurore Perrot, Cyrille Touzeau, et al. · Blood · 43
Efficacy and safety profile of long‐term exposure to lenalidomide in patients with recurrent multiple myeloma
2013 · Guillemette Fouquet, Stéphanie Tardy, et al. · Cancer · 32
PDF
Tyrosine Kinase Inhibitors Induce Down-Regulation of c-Kit by Targeting the ATP Pocket
2013 · Diane D'allard, Julie Gay, et al. · PLoS ONE · 30
PDF
NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents
2018 · Pedro Henrique Prata, Cécile Bally, et al. · Haematologica · 25
PDF
Waldenstrom Macroglobulinemia
2008 · Xavier Leleu, Aldo M. Roccaro, et al. · Cancer Letters · 24
Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine
2015 · J Desoutter, J Gay, et al. · Leukemia · 21
A phase 2 Study of teclistamab in combination with daratumumab in elderly patients with newly diagnosed multiple myeloma: The IFM2021-01 teclille trial, cohort a
2025 · Salomon Manier, Jerome Lambert, et al. · Blood · 20
PDF
Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia
2011 · C. Hochart, C. Berthon, et al. · Médecine et Maladies Infectieuses · 20
Blinatumomab for Patients with Richter Syndrome: Final Results of the Phase 2 Blinart Trial from the Filo Group
2022 · Romain Guieze, Loic Ysebaert, et al. · Blood · 17
Update on therapeutic options in Waldenström macroglobulinemia
2008 · Xavier Leleu, Julie Gay, et al. · European Journal Of Haematology · 17
PDF
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
2024 · Romain Guièze, Loïc Ysebaert, et al. · Nature Communications · 14
PDF
Iberdomide, ixazomib and dexamethasone in elderly patients with multiple myeloma at first relapse
2025 · Cyrille Touzeau, Xavier Leleu, et al. · British Journal of Haematology · 12
PDF
IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia
2016 · Eileen Boyle, Salomon Manier, et al. · Clinical Cancer Research · 11
Genomic Studies Have Identified Multiple Mechanisms of Genetic Changes in Waldenström Macroglobulinemia
2013 · Stéphanie Poulain, Charles Herbaux, et al. · Clinical Lymphoma Myeloma & Leukemia · 10
Bortezomib and Waldenstrom's macroglobulinemia
2009 · Laurent Pascal, Julie Gay, et al. · Expert Opinion on Pharmacotherapy · 10
Blinatumomab for Patients with Richter's Syndrome: A Multicenter Phase 2 Trial from the Filo Group
2021 · Romain Guieze, Loic Ysebaert, et al. · Blood · 9
Preemptive Rituximab Infusions Efficiently Prevent Relapses In Acquired Thrombotic Thrombocytopenic Purpura. Experience Of The French Thrombotic Microangiopathies Reference Center
2013 · Miguel HIE, Julie Gay, et al. · Blood · 7
The Spectrum of Chronic CD8+ T-Cell Expansions: Clinical Features in 14 Patients
2014 · Etienne Ghrenassia, Louise Roulin, et al. · PLoS ONE · 6
PDF
Molecular Prognostic Factors in Acute Myeloid Leukemia (AML) Patients Receiving First Line Therapy with Azacytidine (AZA)
2014 · Judith Desoutter, Julie Gay, et al. · Blood · 5
Works count: 71
Citation count: 1,398
H-index: 16
I10-index: 21
Year
Topic
Type